Richelle Candice Charles, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Typhoid Fever | 21 | 2024 | 196 | 5.640 |
Why?
|
Cholera | 44 | 2024 | 785 | 5.240 |
Why?
|
Antibodies, Bacterial | 42 | 2024 | 1469 | 4.310 |
Why?
|
Vibrio cholerae O1 | 26 | 2024 | 242 | 3.880 |
Why?
|
Salmonella typhi | 18 | 2024 | 200 | 3.640 |
Why?
|
O Antigens | 22 | 2024 | 193 | 3.080 |
Why?
|
Cholera Vaccines | 22 | 2024 | 268 | 2.890 |
Why?
|
Immunoglobulin A | 34 | 2024 | 992 | 2.530 |
Why?
|
Vibrio cholerae | 14 | 2023 | 806 | 1.840 |
Why?
|
Bangladesh | 36 | 2023 | 687 | 1.570 |
Why?
|
Antigens, Bacterial | 9 | 2019 | 1170 | 1.520 |
Why?
|
Immunoglobulin M | 24 | 2024 | 1538 | 1.370 |
Why?
|
Antibodies, Viral | 20 | 2023 | 3164 | 1.300 |
Why?
|
Paratyphoid Fever | 6 | 2022 | 35 | 1.260 |
Why?
|
Vibrio cholerae O139 | 5 | 2023 | 54 | 1.100 |
Why?
|
Immunoglobulin G | 36 | 2024 | 4554 | 1.090 |
Why?
|
Salmonella enterica | 2 | 2024 | 75 | 0.800 |
Why?
|
Bartonella henselae | 1 | 2021 | 16 | 0.800 |
Why?
|
Immunologic Memory | 13 | 2022 | 1348 | 0.800 |
Why?
|
Cat-Scratch Disease | 1 | 2021 | 23 | 0.790 |
Why?
|
Salmonella paratyphi A | 7 | 2024 | 47 | 0.790 |
Why?
|
Serologic Tests | 2 | 2020 | 374 | 0.780 |
Why?
|
Immunity, Mucosal | 4 | 2020 | 491 | 0.760 |
Why?
|
Immunoassay | 2 | 2020 | 752 | 0.710 |
Why?
|
Vaccines, Conjugate | 11 | 2023 | 331 | 0.690 |
Why?
|
Vaccination | 17 | 2024 | 3256 | 0.680 |
Why?
|
Carrier State | 4 | 2021 | 518 | 0.620 |
Why?
|
Magnetite Nanoparticles | 2 | 2017 | 322 | 0.620 |
Why?
|
Bacteremia | 7 | 2015 | 962 | 0.580 |
Why?
|
Antibody Specificity | 1 | 2019 | 1094 | 0.570 |
Why?
|
Immunity, Humoral | 5 | 2020 | 596 | 0.570 |
Why?
|
DNA Probes | 1 | 2016 | 560 | 0.520 |
Why?
|
Cholera Toxin | 12 | 2024 | 553 | 0.500 |
Why?
|
Antibodies, Neutralizing | 7 | 2022 | 1970 | 0.470 |
Why?
|
Salmonella | 4 | 2023 | 129 | 0.450 |
Why?
|
Antibody Formation | 8 | 2024 | 1402 | 0.440 |
Why?
|
Biliary Tract | 1 | 2013 | 134 | 0.430 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3130 | 0.420 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3236 | 0.420 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2016 | 602 | 0.400 |
Why?
|
Point-of-Care Systems | 1 | 2020 | 1175 | 0.400 |
Why?
|
B-Lymphocytes | 11 | 2022 | 4664 | 0.380 |
Why?
|
Vaccines, Inactivated | 8 | 2023 | 184 | 0.360 |
Why?
|
Mucous Membrane | 3 | 2019 | 670 | 0.350 |
Why?
|
Typhoid-Paratyphoid Vaccines | 2 | 2020 | 38 | 0.350 |
Why?
|
Haiti | 9 | 2023 | 551 | 0.350 |
Why?
|
Lymph Nodes | 1 | 2021 | 3465 | 0.350 |
Why?
|
Lymphocytes | 3 | 2022 | 2614 | 0.340 |
Why?
|
Bacterial Proteins | 5 | 2014 | 3843 | 0.340 |
Why?
|
Lipopolysaccharides | 9 | 2024 | 2211 | 0.330 |
Why?
|
Antibodies, Monoclonal | 3 | 2021 | 9274 | 0.330 |
Why?
|
Disease Outbreaks | 6 | 2018 | 1768 | 0.330 |
Why?
|
Cross Reactions | 5 | 2022 | 841 | 0.320 |
Why?
|
Child, Preschool | 28 | 2024 | 40955 | 0.320 |
Why?
|
Interferon-gamma | 2 | 2014 | 3199 | 0.310 |
Why?
|
Antibody-Producing Cells | 5 | 2021 | 143 | 0.310 |
Why?
|
Host-Pathogen Interactions | 2 | 2014 | 1477 | 0.310 |
Why?
|
Salmonella typhimurium | 1 | 2009 | 351 | 0.300 |
Why?
|
Leukocytes, Mononuclear | 4 | 2017 | 1835 | 0.290 |
Why?
|
Clinical Laboratory Techniques | 3 | 2020 | 740 | 0.280 |
Why?
|
Neuraminidase | 3 | 2022 | 210 | 0.280 |
Why?
|
Sensitivity and Specificity | 10 | 2020 | 14720 | 0.270 |
Why?
|
Humans | 98 | 2024 | 742088 | 0.260 |
Why?
|
Child | 33 | 2024 | 77478 | 0.250 |
Why?
|
Adult | 49 | 2024 | 213712 | 0.250 |
Why?
|
Vaccines, Combined | 2 | 2021 | 68 | 0.240 |
Why?
|
Shigella Vaccines | 1 | 2023 | 7 | 0.230 |
Why?
|
Proteome | 1 | 2013 | 1790 | 0.230 |
Why?
|
Young Adult | 26 | 2023 | 56350 | 0.230 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2009 | 1119 | 0.230 |
Why?
|
Shigella | 1 | 2023 | 73 | 0.220 |
Why?
|
Dysentery, Bacillary | 1 | 2023 | 75 | 0.220 |
Why?
|
Adolescent | 28 | 2024 | 85649 | 0.220 |
Why?
|
Proteomics | 4 | 2022 | 3618 | 0.210 |
Why?
|
Cytokines | 4 | 2020 | 7317 | 0.210 |
Why?
|
Blood Group Antigens | 1 | 2023 | 179 | 0.210 |
Why?
|
Administration, Oral | 10 | 2021 | 3913 | 0.200 |
Why?
|
Zingiberales | 1 | 2000 | 1 | 0.200 |
Why?
|
Guaiacol | 1 | 2000 | 5 | 0.200 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3862 | 0.200 |
Why?
|
Agglutination | 1 | 2020 | 43 | 0.200 |
Why?
|
Flank Pain | 1 | 2021 | 43 | 0.190 |
Why?
|
Animals, Suckling | 1 | 2020 | 72 | 0.190 |
Why?
|
Seroepidemiologic Studies | 4 | 2023 | 402 | 0.190 |
Why?
|
Polymerase Chain Reaction | 3 | 2021 | 6171 | 0.190 |
Why?
|
Immunoglobulin Isotypes | 1 | 2021 | 158 | 0.190 |
Why?
|
Tetanus Toxin | 2 | 2023 | 49 | 0.190 |
Why?
|
Sanitation | 2 | 2011 | 93 | 0.190 |
Why?
|
Nucleocapsid Proteins | 1 | 2020 | 77 | 0.180 |
Why?
|
Carotid Artery Injuries | 1 | 2000 | 96 | 0.180 |
Why?
|
Interleukin-23 Subunit p19 | 1 | 2019 | 23 | 0.180 |
Why?
|
Cats | 1 | 2021 | 998 | 0.180 |
Why?
|
Feces | 5 | 2018 | 1394 | 0.170 |
Why?
|
Female | 49 | 2022 | 379592 | 0.170 |
Why?
|
Middle Aged | 35 | 2022 | 213127 | 0.170 |
Why?
|
Urine | 1 | 2021 | 370 | 0.170 |
Why?
|
Klebsiella pneumoniae | 1 | 2021 | 246 | 0.170 |
Why?
|
Ceramides | 1 | 2000 | 198 | 0.170 |
Why?
|
Male | 44 | 2022 | 349538 | 0.160 |
Why?
|
Immune Evasion | 1 | 2022 | 360 | 0.160 |
Why?
|
Nausea | 1 | 2021 | 665 | 0.160 |
Why?
|
Phosphotransferases (Nitrogenous Group Acceptor) | 1 | 2017 | 5 | 0.160 |
Why?
|
Viral Load | 3 | 2022 | 3292 | 0.160 |
Why?
|
Reproducibility of Results | 4 | 2020 | 19862 | 0.150 |
Why?
|
Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2017 | 23 | 0.150 |
Why?
|
Infant | 11 | 2023 | 35070 | 0.150 |
Why?
|
Fever | 2 | 2023 | 1612 | 0.150 |
Why?
|
Receptors, IgG | 1 | 2020 | 582 | 0.150 |
Why?
|
Diarrhea | 3 | 2023 | 1343 | 0.150 |
Why?
|
Pandemics | 10 | 2023 | 8328 | 0.150 |
Why?
|
Bacteriological Techniques | 1 | 2018 | 276 | 0.140 |
Why?
|
Flagellin | 1 | 2017 | 125 | 0.140 |
Why?
|
Immunity, Innate | 2 | 2019 | 2956 | 0.140 |
Why?
|
Escherichia coli | 2 | 2021 | 4214 | 0.140 |
Why?
|
Antigens, Viral | 1 | 2020 | 1034 | 0.140 |
Why?
|
Bayes Theorem | 3 | 2023 | 2303 | 0.140 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2019 | 436 | 0.140 |
Why?
|
Immunologic Tests | 1 | 2016 | 103 | 0.130 |
Why?
|
General Practitioners | 1 | 2016 | 103 | 0.130 |
Why?
|
Cohort Studies | 9 | 2022 | 40450 | 0.130 |
Why?
|
Chromatography, Affinity | 2 | 2020 | 549 | 0.130 |
Why?
|
Travel | 1 | 2021 | 788 | 0.130 |
Why?
|
Bacterial Shedding | 1 | 2014 | 10 | 0.130 |
Why?
|
Plasma | 1 | 2018 | 575 | 0.120 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2018 | 563 | 0.120 |
Why?
|
HIV Antibodies | 1 | 2020 | 1320 | 0.120 |
Why?
|
Microspheres | 1 | 2016 | 777 | 0.120 |
Why?
|
Bacterial Load | 1 | 2014 | 153 | 0.120 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2015 | 323 | 0.110 |
Why?
|
Blood Bactericidal Activity | 4 | 2015 | 126 | 0.110 |
Why?
|
Nucleic Acids | 1 | 2015 | 181 | 0.110 |
Why?
|
Mice | 14 | 2023 | 81045 | 0.110 |
Why?
|
RNA, Bacterial | 2 | 2011 | 391 | 0.110 |
Why?
|
Biosensing Techniques | 2 | 2017 | 668 | 0.110 |
Why?
|
Gallbladder | 1 | 2014 | 301 | 0.110 |
Why?
|
RNA | 1 | 2023 | 2747 | 0.110 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2000 | 1873 | 0.110 |
Why?
|
Blood | 2 | 2016 | 598 | 0.110 |
Why?
|
Nepal | 1 | 2013 | 294 | 0.110 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2015 | 484 | 0.110 |
Why?
|
Animals | 16 | 2023 | 168561 | 0.100 |
Why?
|
Protein Array Analysis | 1 | 2013 | 411 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1575 | 0.100 |
Why?
|
T-Lymphocytes | 5 | 2021 | 10163 | 0.100 |
Why?
|
Bacteriophages | 1 | 2014 | 354 | 0.100 |
Why?
|
Severity of Illness Index | 4 | 2022 | 15530 | 0.100 |
Why?
|
Immunization, Secondary | 3 | 2021 | 340 | 0.090 |
Why?
|
Oligosaccharides | 1 | 2012 | 414 | 0.090 |
Why?
|
Virulence | 2 | 2014 | 1328 | 0.090 |
Why?
|
Monocytes | 1 | 2019 | 2593 | 0.090 |
Why?
|
Gene Expression Profiling | 4 | 2018 | 9410 | 0.090 |
Why?
|
Weight Loss | 1 | 2021 | 2604 | 0.090 |
Why?
|
Species Specificity | 2 | 2015 | 2479 | 0.090 |
Why?
|
Water Supply | 1 | 2010 | 214 | 0.090 |
Why?
|
Rabbits | 3 | 2023 | 4886 | 0.090 |
Why?
|
Bacterial Infections | 1 | 2017 | 1389 | 0.080 |
Why?
|
Anti-Bacterial Agents | 3 | 2018 | 7153 | 0.080 |
Why?
|
Epidemics | 1 | 2014 | 521 | 0.080 |
Why?
|
Disease Models, Animal | 7 | 2023 | 18006 | 0.080 |
Why?
|
Vaccines | 1 | 2016 | 817 | 0.080 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 1915 | 0.080 |
Why?
|
RNA, Messenger | 4 | 2016 | 13029 | 0.080 |
Why?
|
Diagnostic Tests, Routine | 1 | 2013 | 783 | 0.070 |
Why?
|
Bacterial Vaccines | 1 | 2009 | 402 | 0.070 |
Why?
|
Leptin | 1 | 2015 | 1593 | 0.070 |
Why?
|
Communicable Diseases | 1 | 2015 | 878 | 0.070 |
Why?
|
Genes, Bacterial | 1 | 2010 | 1078 | 0.070 |
Why?
|
Asia | 2 | 2018 | 607 | 0.070 |
Why?
|
Fluid Therapy | 1 | 2010 | 592 | 0.070 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2183 | 0.070 |
Why?
|
Antitoxins | 2 | 2019 | 82 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4438 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3760 | 0.070 |
Why?
|
Reagent Kits, Diagnostic | 2 | 2018 | 224 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12958 | 0.070 |
Why?
|
Epitopes | 2 | 2022 | 2569 | 0.070 |
Why?
|
Administration, Cutaneous | 2 | 2020 | 711 | 0.060 |
Why?
|
Massachusetts | 3 | 2023 | 8662 | 0.060 |
Why?
|
Genetic Variation | 2 | 2017 | 6540 | 0.060 |
Why?
|
Aged | 9 | 2024 | 162944 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13256 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 2012 | 1837 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 2014 | 5519 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2013 | 19223 | 0.060 |
Why?
|
Enterotoxins | 2 | 2016 | 368 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2203 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3839 | 0.050 |
Why?
|
Shigella flexneri | 1 | 2023 | 132 | 0.050 |
Why?
|
Th17 Cells | 2 | 2022 | 765 | 0.050 |
Why?
|
Phosphoproteins | 2 | 2020 | 2440 | 0.050 |
Why?
|
Family Characteristics | 2 | 2018 | 999 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2014 | 4379 | 0.050 |
Why?
|
Convalescence | 1 | 2021 | 105 | 0.050 |
Why?
|
Evolution, Molecular | 2 | 2022 | 1937 | 0.050 |
Why?
|
France | 3 | 2016 | 517 | 0.050 |
Why?
|
Escape Reaction | 1 | 2000 | 54 | 0.050 |
Why?
|
Binding Sites, Antibody | 1 | 2021 | 349 | 0.050 |
Why?
|
Intubation | 1 | 2020 | 141 | 0.050 |
Why?
|
Territoriality | 1 | 1999 | 6 | 0.050 |
Why?
|
Plants, Medicinal | 1 | 2000 | 167 | 0.050 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 128 | 0.050 |
Why?
|
HL-60 Cells | 1 | 2020 | 365 | 0.040 |
Why?
|
Genome, Bacterial | 2 | 2018 | 754 | 0.040 |
Why?
|
Diazepam | 1 | 2000 | 205 | 0.040 |
Why?
|
Limit of Detection | 1 | 2020 | 264 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2022 | 425 | 0.040 |
Why?
|
Vocalization, Animal | 1 | 1999 | 87 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2023 | 77098 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 21719 | 0.040 |
Why?
|
Exploratory Behavior | 1 | 2000 | 270 | 0.040 |
Why?
|
Hospitalization | 4 | 2021 | 10232 | 0.040 |
Why?
|
Immunization Schedule | 1 | 2020 | 221 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2021 | 908 | 0.040 |
Why?
|
Avoidance Learning | 1 | 2000 | 233 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 633 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 4751 | 0.040 |
Why?
|
Bacterial Toxins | 2 | 2016 | 933 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2022 | 573 | 0.040 |
Why?
|
Biotechnology | 1 | 2020 | 278 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2021 | 724 | 0.040 |
Why?
|
Tunica Intima | 1 | 2000 | 464 | 0.040 |
Why?
|
Coronavirus | 1 | 2020 | 158 | 0.040 |
Why?
|
Anti-Anxiety Agents | 1 | 2000 | 390 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20086 | 0.040 |
Why?
|
Pakistan | 1 | 2018 | 296 | 0.040 |
Why?
|
Transgenes | 1 | 2021 | 1009 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 24913 | 0.040 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2021 | 218 | 0.040 |
Why?
|
Hemolysin Proteins | 1 | 2017 | 113 | 0.040 |
Why?
|
Escherichia coli Proteins | 2 | 2016 | 1052 | 0.040 |
Why?
|
Polysaccharides, Bacterial | 1 | 2020 | 578 | 0.040 |
Why?
|
Phylogeny | 2 | 2018 | 2797 | 0.040 |
Why?
|
Glycosylation | 1 | 2020 | 1123 | 0.040 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2021 | 359 | 0.040 |
Why?
|
Peptides | 1 | 2009 | 4392 | 0.040 |
Why?
|
Plant Extracts | 1 | 2000 | 469 | 0.040 |
Why?
|
Acute Disease | 2 | 2018 | 7141 | 0.040 |
Why?
|
Protein Subunits | 1 | 2020 | 960 | 0.040 |
Why?
|
Hyperplasia | 1 | 2000 | 1183 | 0.040 |
Why?
|
Gene Transfer, Horizontal | 1 | 2017 | 145 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2022 | 2014 | 0.040 |
Why?
|
Hybridomas | 1 | 2017 | 452 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15108 | 0.040 |
Why?
|
Dependovirus | 1 | 2021 | 706 | 0.030 |
Why?
|
Africa | 1 | 2018 | 670 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2022 | 13921 | 0.030 |
Why?
|
North America | 1 | 2019 | 1249 | 0.030 |
Why?
|
Oxides | 1 | 2017 | 405 | 0.030 |
Why?
|
Immunization Programs | 1 | 2018 | 259 | 0.030 |
Why?
|
Age Factors | 3 | 2021 | 18355 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 609 | 0.030 |
Why?
|
Fluorescence Polarization | 1 | 2015 | 132 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2020 | 57683 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 1284 | 0.030 |
Why?
|
Public Health | 2 | 2023 | 2594 | 0.030 |
Why?
|
Polysaccharides | 1 | 2022 | 1051 | 0.030 |
Why?
|
Stress, Psychological | 2 | 2000 | 4229 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2021 | 2378 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1011 | 0.030 |
Why?
|
Duodenum | 1 | 2018 | 483 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23387 | 0.030 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2014 | 82 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 944 | 0.030 |
Why?
|
Mutation | 3 | 2022 | 29717 | 0.030 |
Why?
|
Adhesins, Bacterial | 1 | 2014 | 119 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3266 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10248 | 0.030 |
Why?
|
Social Behavior | 1 | 2000 | 1128 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2000 | 1504 | 0.030 |
Why?
|
Models, Biological | 2 | 2009 | 9581 | 0.030 |
Why?
|
Microbial Viability | 1 | 2015 | 234 | 0.030 |
Why?
|
Language | 1 | 2023 | 1458 | 0.030 |
Why?
|
Hot Temperature | 1 | 2019 | 1355 | 0.030 |
Why?
|
Zinc | 1 | 2017 | 683 | 0.030 |
Why?
|
Prophages | 1 | 2013 | 38 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 428 | 0.030 |
Why?
|
Carotid Stenosis | 1 | 2000 | 854 | 0.030 |
Why?
|
History, 21st Century | 1 | 2018 | 1533 | 0.030 |
Why?
|
Plasmids | 1 | 2017 | 2305 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2024 | 25575 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 6382 | 0.030 |
Why?
|
Point Mutation | 1 | 2017 | 1624 | 0.030 |
Why?
|
Antibodies | 1 | 2020 | 2459 | 0.030 |
Why?
|
Time Factors | 3 | 2020 | 40054 | 0.030 |
Why?
|
Colony Count, Microbial | 1 | 2012 | 331 | 0.030 |
Why?
|
Haplotypes | 1 | 2018 | 2781 | 0.030 |
Why?
|
Genomics | 2 | 2018 | 5692 | 0.030 |
Why?
|
Cell Separation | 1 | 2017 | 1749 | 0.030 |
Why?
|
Models, Molecular | 1 | 2022 | 5454 | 0.020 |
Why?
|
Erythromycin | 1 | 2010 | 120 | 0.020 |
Why?
|
Rehydration Solutions | 1 | 2010 | 47 | 0.020 |
Why?
|
Vaccines, Attenuated | 1 | 2012 | 341 | 0.020 |
Why?
|
Immunization | 1 | 2015 | 1255 | 0.020 |
Why?
|
History, 20th Century | 1 | 2018 | 2739 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2012 | 664 | 0.020 |
Why?
|
Caribbean Region | 1 | 2010 | 194 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5062 | 0.020 |
Why?
|
Serotyping | 1 | 2010 | 338 | 0.020 |
Why?
|
Tetracycline | 1 | 2010 | 214 | 0.020 |
Why?
|
History, 18th Century | 1 | 2010 | 214 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8297 | 0.020 |
Why?
|
Latin America | 1 | 2010 | 381 | 0.020 |
Why?
|
Protein Binding | 1 | 2022 | 9387 | 0.020 |
Why?
|
Neutrophils | 1 | 2022 | 3711 | 0.020 |
Why?
|
Iron | 1 | 2017 | 1773 | 0.020 |
Why?
|
Mice, Inbred DBA | 2 | 2000 | 642 | 0.020 |
Why?
|
Doxycycline | 1 | 2010 | 326 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2014 | 2723 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 21821 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 12071 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2015 | 2557 | 0.020 |
Why?
|
HIV Infections | 1 | 2015 | 16678 | 0.020 |
Why?
|
Biological Evolution | 1 | 2014 | 1074 | 0.020 |
Why?
|
Age Distribution | 1 | 2014 | 2900 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9305 | 0.020 |
Why?
|
Malnutrition | 1 | 2014 | 625 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 766 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2015 | 10472 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3679 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2010 | 2049 | 0.020 |
Why?
|
Th1 Cells | 1 | 2012 | 1056 | 0.020 |
Why?
|
Th2 Cells | 1 | 2012 | 1049 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3937 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2012 | 1000 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10372 | 0.020 |
Why?
|
Incidence | 2 | 2022 | 20928 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6756 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2271 | 0.020 |
Why?
|
Mammography | 1 | 1997 | 2474 | 0.020 |
Why?
|
World Health Organization | 1 | 2010 | 1317 | 0.020 |
Why?
|
Mass Screening | 2 | 1997 | 5238 | 0.010 |
Why?
|
Apoptosis | 1 | 2000 | 9715 | 0.010 |
Why?
|
Base Sequence | 1 | 2015 | 12797 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6608 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2018 | 12017 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 3038 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3920 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5385 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4929 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2010 | 4742 | 0.010 |
Why?
|
Risk Factors | 2 | 2022 | 72145 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12242 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29010 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2010 | 4801 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 1997 | 20774 | 0.010 |
Why?
|
Ultrasonics | 1 | 1999 | 212 | 0.010 |
Why?
|
Urination | 1 | 1999 | 204 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2000 | 15244 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9639 | 0.010 |
Why?
|
Aggression | 1 | 1999 | 753 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12164 | 0.010 |
Why?
|
Social Environment | 1 | 1999 | 1023 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 62966 | 0.010 |
Why?
|
Liver | 1 | 1989 | 7470 | 0.010 |
Why?
|
Cross-Cultural Comparison | 1 | 1997 | 651 | 0.010 |
Why?
|
United States | 1 | 2018 | 69693 | 0.010 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 1989 | 74 | 0.010 |
Why?
|
Program Evaluation | 1 | 1996 | 2485 | 0.000 |
Why?
|
Data Collection | 1 | 1997 | 3339 | 0.000 |
Why?
|
Quality Assurance, Health Care | 1 | 1997 | 2211 | 0.000 |
Why?
|
Anxiety | 1 | 2000 | 4279 | 0.000 |
Why?
|
Models, Anatomic | 1 | 1989 | 690 | 0.000 |
Why?
|
Tissue Distribution | 1 | 1989 | 2335 | 0.000 |
Why?
|
Staining and Labeling | 1 | 1989 | 1099 | 0.000 |
Why?
|
Referral and Consultation | 1 | 1997 | 3527 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1989 | 11363 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1989 | 8925 | 0.000 |
Why?
|